Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global – Liquid Biopsy Market


6. Market Share – Global Liquid Biopsy

6.1 By Region
6.2 By Cancer
6.3 By Product
6.4 By Circulating Biomarkers
6.5 By Sample


7. Region – Liquid Biopsy Market

7.1 North America
7.2 Europe
7.3 Asia - Pacific
7.4 Latin America
7.5 Middle East & Africa


8. Cancer – Liquid Biopsy Market

8.1 Lung Cancer
8.2 Breast Cancer
8.3 Colorectal Cancer
8.4 Prostate Cancer
8.5 Others


9. Product – Liquid Biopsy Market

9.1 Kits & Consumables
9.2 Instruments
9.3 Services


10. Circulating Biomarkers – Liquid Biopsy Market

10.1 Circulating Tumor cell (CTCs)
10.2 Circulating Tumor DNA (ctDNA)
10.3 Extracellular Vesicles (EVs)
10.4 Other Biomarkers (cell free DNA, etc)


11. Clinical Application – Liquid Biopsy Market

11.1 Monitoring
11.2 Prognosis
11.3 Theranostics
11.4 Screening


12. Sample – Liquid Biopsy Market

12.1 Plasma / Serum
12.2 Urine
12.3 Others


13. Porters Five Forces

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes


14. Company Analysis

14.1 Thermo Fisher Scientific, Inc

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Financial Insights

14.2 Guardant Health Inc

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Financial Insights

14.3 EXACT Sciences Corp.

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Financial Insights

14.4 Illumina Inc.

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Financial Insights

14.5 Bio – Rad Laboratories

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Financial Insights

14.6 Biocept

14.6.1 Overview
14.6.2 Recent Development
14.6.3 Financial Insights

14.7 NeoGenomics, Inc.

14.7.1 Overview
14.7.2 Recent Development
14.7.3 Financial Insights

14.8 Qiagen NV

14.8.1 Overview
14.8.2 Recent Development
14.8.3 Financial Insights



List of Figures

Figure-01: Global – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-02: Global – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-03: North America – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-04: North America – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-05: Europe – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-06: Europe – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-07: Asia - Pacific – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-08: Asia - Pacific – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-09: Latin America – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-10: Latin America – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-11: Middle East & Africa – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-12: Middle East & Africa – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-13: Lung Cancer – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-14: Lung Cancer – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-15: Breast Cancer – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-16: Breast Cancer – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-17: Colorectal Cancer – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-18: Colorectal Cancer – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-19: Prostate Cancer – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-20: Prostate Cancer – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-21: Others – Liquid Biopsy Market (Million US$), 2016 – 2021
Figure-22: Others – Forecast for Liquid Biopsy Market (Million US$), 2022 – 2027
Figure-23: Product – Kits & Consumables Market (Million US$), 2016 – 2021
Figure-24: Product – Forecast for Kits & Consumables Market (Million US$), 2022 – 2027
Figure-25: Product – Instruments Market (Million US$), 2016 – 2021
Figure-26: Product – Forecast for Instruments Market (Million US$), 2022 – 2027
Figure-27: Product – Services Market (Million US$), 2016 – 2021
Figure-28: Product – Forecast for Services Market (Million US$), 2022 – 2027
Figure-29: Circulating Biomarkers – Circulating Tumor cell (CTCs) Market (Million US$), 2016 – 2021
Figure-30: Circulating Biomarkers – Forecast for Circulating Tumor cell (CTCs) Market (Million US$), 2022 – 2027
Figure-31: Circulating Biomarkers – Circulating Tumor DNA (ctDNA) Market (Million US$), 2016 – 2021
Figure-32: Circulating Biomarkers – Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2022 – 2027
Figure-33: Circulating Biomarkers – Extracellular Vesicles (EVs) Market (Million US$), 2016 – 2021
Figure-34: Circulating Biomarkers – Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2022 – 2027
Figure-35: Circulating Biomarkers – Other Biomarkers (cell free DNA, etc) Market (Million US$), 2016 – 2021
Figure-36: Circulating Biomarkers – Forecast for Other Biomarkers (cell free DNA, etc) Market (Million US$), 2022 – 2027
Figure-37: Clinical Application – Monitoring Market (Million US$), 2016 – 2021
Figure-38: Clinical Application – Forecast for Monitoring Market (Million US$), 2022 – 2027
Figure-39: Clinical Application – Prognosis Market (Million US$), 2016 – 2021
Figure-40: Clinical Application – Forecast for Prognosis Market (Million US$), 2022 – 2027
Figure-41: Clinical Application – Theranostics Market (Million US$), 2016 – 2021
Figure-42: Clinical Application – Forecast for Theranostics Market (Million US$), 2022 – 2027
Figure-43: Clinical Application – Screening Market (Million US$), 2016 – 2021
Figure-44: Clinical Application – Forecast for Screening Market (Million US$), 2022 – 2027
Figure-45: Sample – Plasma / Serum Market (Million US$), 2016 – 2021
Figure-46: Sample – Forecast for Plasma / Serum Market (Million US$), 2022 – 2027
Figure-47: Sample – Urine Market (Million US$), 2016 – 2021
Figure-48: Sample – Forecast for Urine Market (Million US$), 2022 – 2027
Figure-49: Sample – Others Market (Million US$), 2016 – 2021
Figure-50: Sample – Forecast for Others Market (Million US$), 2022 – 2027
Figure-51: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2016 – 2021
Figure-52: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-53: Guardant Health , Inc – Global Revenue (Million US$), 2016 – 2021
Figure-54: Guardant Health , Inc – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-55: EXACT Sciences Corp. – Global Revenue (Million US$), 2016 – 2021
Figure-56: EXACT Sciences Corp. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-57: Illumina Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-58: Illumina Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-59: Bio – Rad Laboratories – Global Revenue (Million US$), 2016 – 2021
Figure-60: Bio – Rad Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-61: Biocept – Global Revenue (Million US$), 2016 – 2021
Figure-62: Biocept – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-63: NeoGenomics, Inc. – Global Revenue (Million US$), 2016 – 2021
Figure-64: NeoGenomics, Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-65: Qiagen NV – Global Revenue (Million US$), 2016 – 2021
Figure-66: Qiagen NV – Forecast for Global Revenue (Million US$), 2022 – 2027

List of Tables

Table-01: Global – Liquid Biopsy Market Share by Region (Percent), 2016 – 2021
Table-02: Global – Forecast for Liquid Biopsy Market Share by Region (Percent), 2022 – 2027
Table-03: Global – Liquid Biopsy Market Share by Cancer (Percent), 2016 – 2021
Table-04: Global – Forecast for Liquid Biopsy Market Share by Cancer (Percent), 2022 – 2027
Table-05: Global – Liquid Biopsy Market Share by Product (Percent), 2016 – 2021
Table-06: Global – Forecast for Liquid Biopsy Market Share by Product (Percent), 2022 – 2027
Table-07: Global – Liquid Biopsy Market Share by Circulating Biomarkers (Percent), 2016 – 2021
Table-08: Global – Forecast for Liquid Biopsy Market Share by Circulating Biomarkers (Percent), 2022 – 2027
Table-09: Global – Liquid Biopsy Market Share by Sample (Percent), 2016 – 2021
Table-10: Global – Forecast for Liquid Biopsy Market Share by Sample (Percent), 2022 – 2027